These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 9371386)

  • 1. Carboplatin and etoposide with hyperfractionated radiotherapy in children with newly diagnosed diffuse pontine gliomas: a phase I/II study.
    Walter AW; Gajjar A; Ochs JS; Langston JW; Sanford RA; Kun LE; Heideman R
    Med Pediatr Oncol; 1998 Jan; 30(1):28-33. PubMed ID: 9371386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A phase I/II study of carboplatin combined with hyperfractionated radiotherapy for brainstem gliomas.
    Allen J; Siffert J; Donahue B; Nirenberg A; Jakacki R; Robertson P; DaRosso R; Thoron L; Rosovsky M; Pinto R
    Cancer; 1999 Sep; 86(6):1064-9. PubMed ID: 10491535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Phase I study of concurrent RMP-7 and carboplatin with radiation therapy for children with newly diagnosed brainstem gliomas.
    Packer RJ; Krailo M; Mehta M; Warren K; Allen J; Jakacki R; Villablanca JG; Chiba A; Reaman G
    Cancer; 2005 Nov; 104(9):1968-74. PubMed ID: 16177987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. There is no role for hyperfractionated radiotherapy in the management of children with newly diagnosed diffuse intrinsic brainstem tumors: results of a Pediatric Oncology Group phase III trial comparing conventional vs. hyperfractionated radiotherapy.
    Mandell LR; Kadota R; Freeman C; Douglass EC; Fontanesi J; Cohen ME; Kovnar E; Burger P; Sanford RA; Kepner J; Friedman H; Kun LE
    Int J Radiat Oncol Biol Phys; 1999 Mar; 43(5):959-64. PubMed ID: 10192340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective evaluation of radiotherapy with concurrent and adjuvant temozolomide in children with newly diagnosed diffuse intrinsic pontine glioma.
    Jalali R; Raut N; Arora B; Gupta T; Dutta D; Munshi A; Sarin R; Kurkure P
    Int J Radiat Oncol Biol Phys; 2010 May; 77(1):113-8. PubMed ID: 19647954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High dose chemotherapy with autologous bone marrow rescue for children with diffuse pontine brain stem tumors. Children's Cancer Group.
    Dunkel IJ; Garvin JH; Goldman S; Ettinger LJ; Kaplan AM; Cairo M; Li H; Boyett JM; Finlay JL
    J Neurooncol; 1998 Mar; 37(1):67-73. PubMed ID: 9525840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategies in the treatment of diffuse pontine gliomas: the therapeutic role of hyperfractionated radiotherapy and chemotherapy.
    Jennings MT; Freeman ML; Murray MJ
    J Neurooncol; 1996; 28(2-3):207-22. PubMed ID: 8832463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intra-arterial carboplatin and intravenous etoposide for the treatment of recurrent and progressive non-GBM gliomas.
    Newton HB; Slivka MA; Stevens CL; Bourekas EC; Christoforidis GA; Baujan MA; Chakeres DW
    J Neurooncol; 2002 Jan; 56(1):79-86. PubMed ID: 11949830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concurrent accelerated hyperfractionated radiation therapy and carboplatin/etoposide in patients with malignant glioma: long-term results of a phase II study.
    Jeremic B; Shibamoto Y; Grujicic D; Stojanovic M; Milicic B; Nikolic N; Dagovic A; Aleksandrovic J
    J Neurooncol; 2001 Jan; 51(2):133-41. PubMed ID: 11386410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential responsiveness among "high risk" pediatric brain tumors in a pilot study of dose-intensive induction chemotherapy.
    Jennings MT; Cmelak A; Johnson MD; Moots PL; Pais R; Shyr Y
    Pediatr Blood Cancer; 2004 Jul; 43(1):46-54. PubMed ID: 15170889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperfractionated radiation therapy and concurrent low-dose, daily carboplatin/etoposide with or without weekend carboplatin/etoposide chemotherapy in stage III non-small-cell lung cancer: a randomized trial.
    Jeremic B; Shibamoto Y; Acimovic L; Milicic B; Milisavljevic S; Nikolic N; Dagovic A; Aleksandrovic J; Radosavljevic-Asic G
    Int J Radiat Oncol Biol Phys; 2001 May; 50(1):19-25. PubMed ID: 11316542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperfractionated radiation therapy with or without concurrent low-dose daily carboplatin/etoposide for stage III non-small-cell lung cancer: a randomized study.
    Jeremic B; Shibamoto Y; Acimovic L; Milisavljevic S
    J Clin Oncol; 1996 Apr; 14(4):1065-70. PubMed ID: 8648358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A clinical evaluation of combination therapy with radiation, MCNU, carboplatin and IFN-beta or with radiation, MCNU, carboplatin, etoposide and IFN-beta for malignant gliomas].
    Mizumatsu S; Matsumoto K; Maeda Y; Tamiya T; Furuta T; Ohmoto T
    Gan To Kagaku Ryoho; 1998 Nov; 25(13):2055-60. PubMed ID: 9838907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I and pharmacokinetic study of preirradiation chemotherapy with BCNU, cisplatin, etoposide, and accelerated radiation therapy in patients with high-grade glioma.
    Rajkumar SV; Buckner JC; Schomberg PJ; Reid JM; Bagniewski PJ; Ames MM; Cascino TL; Marks RS
    Int J Radiat Oncol Biol Phys; 1998 Dec; 42(5):969-75. PubMed ID: 9869217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination chemotherapy using carboplatin (JM-8) and etoposide (JET therapy) for recurrent malignant gliomas: a phase II study.
    Watanabe K; Kanaya H; Fujiyama Y; Kim P
    Acta Neurochir (Wien); 2002 Dec; 144(12):1265-70; discussion 1270. PubMed ID: 12478337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low grade chiasmatic-hypothalamic glioma-carboplatin and vincristin chemotherapy effectively defers radiotherapy within a comprehensive treatment strategy -- report from the multicenter treatment study for children and adolescents with a low grade glioma -- HIT-LGG 1996 -- of the Society of Pediatric Oncology and Hematology (GPOH).
    Gnekow AK; Kortmann RD; Pietsch T; Emser A
    Klin Padiatr; 2004; 216(6):331-42. PubMed ID: 15565548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of children with brain stem gliomas after treatment with 7800 cGy of hyperfractionated radiotherapy. A Childrens Cancer Group Phase I/II Trial.
    Packer RJ; Boyett JM; Zimmerman RA; Albright AL; Kaplan AM; Rorke LB; Selch MT; Cherlow JM; Finlay JL; Wara WM
    Cancer; 1994 Sep; 74(6):1827-34. PubMed ID: 8082086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperfractionated radiation therapy (HFX RT) followed by multiagent chemotherapy (CHT) in patients with malignant glioma: a phase II study.
    Jeremic B; Grujicic D; Antunovic V; Djuric L; Stojanovic M; Shibamoto Y
    Int J Radiat Oncol Biol Phys; 1994 Dec; 30(5):1179-85. PubMed ID: 7961028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase II study of concurrent accelerated hyperfractionated radiotherapy and carboplatin/oral etoposide for elderly patients with stage III non-small-cell lung cancer.
    Jeremic B; Shibamoto Y; Milicic B; Milisavljevic S; Nikolic N; Dagovic A; Aleksandrovic J; Radosavljevic-Asic G
    Int J Radiat Oncol Biol Phys; 1999 May; 44(2):343-8. PubMed ID: 10760429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nimotuzumab-containing regimen for pediatric diffuse intrinsic pontine gliomas: a retrospective multicenter study and review of the literature.
    Kebudi R; Cakir FB; Bay SB; Gorgun O; Altınok P; Iribas A; Agaoglu FY; Darendeliler E
    Childs Nerv Syst; 2019 Jan; 35(1):83-89. PubMed ID: 30417211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.